as the article states:





































































"ade risks associated with sars-cov-2 has implications for covid-19 and mis-c treatments, b-cell vaccines, sars-cov-2 antibody therapy, and convalescent plasma therapy for patients.  sars-cov-2 antibodies bound to mast cells may be involved in mis-c and